Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies

Aberrant expression of the programmed cell death protein ligand 1 (PD-L1) constitutes one of the main immune evasion mechanisms of cancer cells. The approval of drugs against the PD-1-PD-L1 axis has given new impetus to the chemo-therapy of many malignancies. We performed a literature review from 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Meliante, Piero Giuseppe, Barbato, Christian, Zoccali, Federica, Ralli, Massimo, Greco, Antonio, de Vincentiis, Marco, Colizza, Andrea, Petrella, Carla, Ferraguti, Giampiero, Minni, Antonio, Fiore, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738355/
https://www.ncbi.nlm.nih.gov/pubmed/36499710
http://dx.doi.org/10.3390/ijms232315384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738355/
https://www.ncbi.nlm.nih.gov/pubmed/36499710
http://dx.doi.org/10.3390/ijms232315384

Ejemplares similares